Leflunomide: a review of its use in active rheumatoid arthritis.
about
Leflunomide: a drug with a potential beyond rheumatologyHuman pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing dataA case of severe staphylococcal septicaemia: septic arthritis and a mediastinal abscess following leflunamide therapy for rheumatoid arthritis.Leflunomide for the treatment of rheumatoid arthritis.Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue culturesLeflunomide: long-term clinical experience and new uses.Proposals for leflunomide use to avoid lung injury in patients with rheumatoid arthritis.Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.Teriflunomide: a review of its use in relapsing multiple sclerosis.Leflunomide-induced lung injury that developed after its withdrawal, coinciding with peripheral blood lymphocyte count decrease.Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.Leflunomide in the treatment of rheumatoid arthritis.Leflunomide-associated pancytopenia with or without methotrexate.Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis.Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency.Severe cutaneous adverse drug reaction to leflunomide: a report of two cases.Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.
P2860
Q28294236-726E3F16-E7D4-40D4-9B89-168F42291899Q31044246-E00D7035-B66A-4895-BB56-1F367969272FQ34532176-0B43D349-D20E-477E-BA4A-2667A80E3367Q35143977-DF3DE04A-26DB-42E8-8DA6-C06276C6EC26Q35552648-1C6488B9-CDFF-4260-B53B-3AC0FBBE158BQ36150789-BC4C0B4A-A04F-4D97-A3A9-4763B4FA680BQ37190513-ABAA3F38-FE4C-480E-8CC4-2D310F846456Q38098466-9A754B99-6D5B-4F04-A563-2613585B3CB1Q38160410-1C159AE4-0AC3-453A-95AA-9D75FCCAAF99Q40431026-1C770A52-D945-4730-A454-A36C233D7FC6Q41912381-C623D2B5-B4FD-4DD5-97DA-0F8D489D40A7Q43061691-ACEFD875-6A6E-4485-98AE-4560B0ABD21BQ44929056-D851FC7E-806D-421D-9524-FC801378065BQ45998968-6A3E2F3D-9342-480D-AA47-BB29C1C9C148Q46456972-94CD8D5A-221A-4157-840B-018DDDF4B61BQ46710201-FC600B49-1DF9-4A05-B10A-34AD5151F54AQ53105748-5E9F1FE6-5888-447C-8123-45B46EF87C26
P2860
Leflunomide: a review of its use in active rheumatoid arthritis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Leflunomide: a review of its use in active rheumatoid arthritis.
@ast
Leflunomide: a review of its use in active rheumatoid arthritis.
@en
type
label
Leflunomide: a review of its use in active rheumatoid arthritis.
@ast
Leflunomide: a review of its use in active rheumatoid arthritis.
@en
prefLabel
Leflunomide: a review of its use in active rheumatoid arthritis.
@ast
Leflunomide: a review of its use in active rheumatoid arthritis.
@en
P1433
P1476
Leflunomide: a review of its use in active rheumatoid arthritis.
@en
P2093
P304
P356
10.2165/00003495-199958060-00010
P577
1999-12-01T00:00:00Z
P6179
1037232884